BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35834952)

  • 21. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
    Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X
    Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-1273g-3p modulates activation and apoptosis of hepatic stellate cells by directly targeting PTEN in HCV-related liver fibrosis.
    Niu X; Fu N; Du J; Wang R; Wang Y; Zhao S; Du H; Wang B; Zhang Y; Sun D; Nan Y
    FEBS Lett; 2016 Aug; 590(16):2709-24. PubMed ID: 27423040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F; Fan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3.
    Li H; Zhang L; Cai N; Zhang B; Sun S
    Ann Hepatol; 2021; 23():100305. PubMed ID: 33434689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
    Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
    Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.
    Zheng J; Wu C; Lin Z; Guo Y; Shi L; Dong P; Lu Z; Gao S; Liao Y; Chen B; Yu F
    FEBS J; 2014 Jan; 281(1):88-103. PubMed ID: 24138392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells.
    Kong H; Song Q; Hu W; Guo S; Xiang D; Huang S; Xu X; He J; Pan L; Tao R; Yu H; Huang J
    Parasit Vectors; 2023 Jun; 16(1):184. PubMed ID: 37280619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
    Ma L; Yang X; Wei R; Ye T; Zhou JK; Wen M; Men R; Li P; Dong B; Liu L; Fu X; Xu H; Aqeilan RI; Wei YQ; Yang L; Peng Y
    Cell Death Dis; 2018 Jun; 9(7):718. PubMed ID: 29915227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-92b-3p promotes the progression of liver fibrosis by targeting CREB3L2 through the JAK/STAT signaling pathway.
    Huang W; Ji R; Ge S; Zhou D; Liu Z; Sun Y; Huang W; Lu C
    Pathol Res Pract; 2021 Mar; 219():153367. PubMed ID: 33618248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p/BTG1 pathway.
    Luan SH; Yang YQ; Ye MP; Liu H; Rao QF; Kong JL; Wu FR
    Int J Biol Macromol; 2022 Jun; 211():128-139. PubMed ID: 35561854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3.
    Wang Y; Zhang R; Li J; Han X; Lu H; Su J; Liu Y; Tian X; Wang M; Xiong Y; Lan T; Zhang G; Liu Z
    Exp Biol Med (Maywood); 2022 Oct; 247(19):1712-1731. PubMed ID: 35833537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Mediators Inflamm; 2016; 2016():9856538. PubMed ID: 27610008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression.
    Dou L; Wang S; Sui X; Meng X; Shen T; Huang X; Guo J; Fang W; Man Y; Xi J; Li J
    Cell Physiol Biochem; 2015; 35(4):1413-24. PubMed ID: 25790935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
    Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
    Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate
    Huang W; Huang F; Zhang R; Luo H
    Cell Cycle; 2021; 20(5-6):490-507. PubMed ID: 33550894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types.
    Wang X; Seo W; Park SH; Fu Y; Hwang S; Rodrigues RM; Feng D; Gao B; He Y
    Int J Biol Sci; 2021; 17(4):1153-1167. PubMed ID: 33867837
    [No Abstract]   [Full Text] [Related]  

  • 40. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.
    Ji F; Wang K; Zhang Y; Mao XL; Huang Q; Wang J; Ye L; Li Y
    J Cell Biochem; 2019 Mar; 120(3):4573-4581. PubMed ID: 30368874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.